In lung cancer treatment, the sensitivity of NSCLC cell lines to Smac mimetic, Compound 3/4, alone is related to autocrine-secretion of TNFα and the formation of RIP1-dependent caspase-8-activating complex [14]. The gene discussed is RIPK1; the disease is non-small cell lung carcinoma.